The global mobile cardiac telemetry systems market accounted to US$ 564.8 Mn in 2018 and is expected to grow at a CAGR of 12.4% during the forecast period 2019 – 2027, to account to US$ 1,546.4 Mn by 2027.
Key factors driving the market are, rising prevalence of cardiovascular diseases, benefits of monitoring patients with mobile cardiac telemetry (MCT), and rising geriatric population. However, factors such as stringent regulations for approval, and technical problems associated with the mobile cardiac telemetry (MCT) are likely to restrain the market growth to a certain extent.
Get PDF sample copy: http://bit.ly/2W7Wvtq
Europe cardiac telemetry systems market is expected to grow at highest rate during the forecast period owing to rising prevalence of the cardiovascular diseases, increasing developments in healthcare including, high quality of network of hospitals and medical centres. In addition, emergence of new local players with competitive product portfolio are expected to fuel the market growth in Europe region.
The prominent players operating in mobile cardiac telemetry systems market are, Medtronic, BioTelemetry Inc., Applied Cardiac Systems, Inc, Medicomp Inc, Preventice Services, LLC, The Scottcare Corporation, Medi-Lynx (Subisidiary Of Medicalgorithmics, S.A), Zoll Medical Corporation, Welch Allyn, and Telerhythmics, LLC.
The mobile cardiac telemetry systems market by technology is segmented into lead based and patch based systems. In 2018, the mobile cardiac telemetry systems with lead based segment held a largest market share of 60.1% of the mobile cardiac telemetry systems market, by technology. This segment is also expected to dominate the market in 2027 owing to advancements in ambulatory cardiac monitoring, and increasing rate of heart rhythm disorders. Moreover, the patch-based segment is anticipated to witness the fastest growth rate of 12.7% during the forecast period, 2019 to 2027 owing to advances in the technology of wearable cardiac monitors.
Inquire for discount: https://www.theinsightpartners.com/discount/TIPRE00003486/
Strategic acquisition and product launches were observed as the most adopted strategy in global mobile cardiac telemetry systems industry. Few of the recent product launch and acquisitions are listed below:
2018: Medtronic discontinued marketing for its SEEQ Mobile Cardiac Telemetry (MCT) System to concentrate support on its Reveal LINQ Insertable Cardiac Monitor (ICM) System.
2016: BioTelemetry, Inc acquired Geneva Healthcare, Inc. which is the leading provider of remote monitoring for implantable cardiac devices.
2015: Medicomp launched TelePatch, which was the latest breakthrough in the world of ECG patches.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.